Literature DB >> 18473488

Cervical cancer screening: from molecular basis to diagnostic practice, going through new technologies.

Roberta Zappacosta1, Sandra Rosini.   

Abstract

In the era of Human Papillomavirus (HPV) vaccination, a lot of misunderstanding still exists among healthcare professionals and patients regarding HPV infection. The purpose of this review is to synthesize the clinical molecular mechanisms that contribute to HPV-mediated cervical carcinogenesis, as well as to appraise the current status of new biomarkers and technologies in terms of available data on clinical applications and future promises.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18473488     DOI： 10.1177/153303460800700302

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN： 1533-0338


  3 in total

1.  Automated analysis of fluorescent in situ hybridization (FISH) labeled genetic biomarkers in assisting cervical cancer diagnosis.

Authors:  Xingwei Wang; Bin Zheng; Roy R Zhang; Shibo Li; Xiaodong Chen; John J Mulvihill; Xianglan Lu; Hui Pang; Hong Liu
Journal:  Technol Cancer Res Treat       Date:  2010-06

2.  Analytic and Diagnostic Performances of Human Papillomavirus E6/E7 mRNA Test on up-to 11-Year-Old Liquid-Based Cervical Samples. A Biobank-Based Longitudinal Study.

Authors:  Roberta Zappacosta; Francesca Sablone; Lucia Pansa; Davide Buca; Danilo Buca; Sandra Rosini
Journal:  Int J Mol Sci       Date:  2017-07-11       Impact factor: 5.923

3.  Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.

Authors:  Roberta Zappacosta; Antonella Colasante; Patrizia Viola; Tommaso D'Antuono; Giuseppe Lattanzio; Serena Capanna; Daniela Maria Pia Gatta; Sandra Rosini
Journal:  Biomed Res Int       Date:  2013-11-24       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.